Hospice utilization among Medicare beneficiaries dying from pancreatic cancer

Author:

Paredes Anghela Z.12,Hyer J. Madison12,Tsilimigras Diamantis I.12,Mehta Rittal12,Sahara Kota12,White Susan12,Dillhoff Mary E.12,Ejaz Aslam12,Cloyd Jordan M.12,Pawlik Timothy M.12ORCID

Affiliation:

1. Division of Surgical OncologyThe Ohio State University Wexner Medical Center and James Comprehensive Cancer CenterColumbus Ohio

2. Division of Health Information Management and Systems, The Ohio State Wexner Medical CenterThe Ohio State UniversityColumbus Ohio

Publisher

Wiley

Subject

Oncology,General Medicine,Surgery

Reference46 articles.

1. American Cancer Society.Key statistics for pancreatic cancer.https://www.cancer.org/cancer/pancreatic‐cancer/about/key‐statistics.html. Published 2019. Accessed March 15 2019.

2. FOLFIRINOX or gemcitabine as adjuvant therapy for pancreatic cancer;Conroy T;N Engl J Med,2018

3. Adjuvant treatment of surgically resectable pancreatic ductal adenocarcinoma;Tesfaye AA;Clin Adv Hematol Oncol,2019

4. Impact of immunotherapy after resection of pancreatic cancer;Tran TB;J Am Coll Surg,2019

5. CubanskiJ NeumanT GriffinS DamicoA. Medicare spending at the end of life: a snapshot of beneficiaries who died in 2014 and the cost of their care.2016. Accessed April 1 2019.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3